Behind the Buy: Payors and Providers on AI Adoption
This episode features interviews with payor and provider leaders about what they’re seeing and how they’re thinking about AI. Guided by Julie Yoo, general partner, and Jay Rughani, investment partner at a16z Bio + Health, you'll hear from the executives about how they're utilizing AI, the KPIs they use to gauge effectiveness, and what they consider to be a good partnership.
Raghu Raghurama16z.com
The Little Tech Agendaa16z.com
Engaging the Unengaged at Home with Max Cohen and Cameron Behara16z.com
Evolve or Die: The Future of the Creative Process, Artist Authenticity, and the Value of the Musica16z.com
The State of AI & Educationa16z.com
America's Energy Problem: The Grid That Built America Can’t Power Its Futurea16z.com
Synthesia launches talent experience program to learn from and reward the exceptional actors behindSynthesia
Comparing Reachability Analysis ProvidersSocket
Preview of .NET resource providersPulumi
State of DevSecOpsDatadoghq
Should you build or buy an API documentation tool?Mintlify
AI Statistics 2026: Adoption, Usage & Workforce TrendsSynthesia
PolinRider Spreads Through Compromised GitHub Accounts and PackagistSocket
Pulumi Release Notes: Colorized Stack Traces, Output Methods for JSON, OIDC integration, and muchPulumi
Build vs buy AI agents: why custom solutions win long-termRetool
How Pernod Ricard Deployed Enterprise AI to 28 Countries | Retool BlogRetool
Questions to Ask Your Hardened Image ProviderDocker
Working with domainsVercel
How to build scalable AI applicationsVercel
State of Voice Tech 2022: New Report Highlights Biggest Voice Tech Adoption MotivatorsDeepgram
